What can modelling do for you? Rational design and interpretation of clinical studies integrating clinical knowledge with predictive tools

Dr. Catriona Waitt
Reader in Clinical Pharmacology,University of Liverpool, Liverpool, United Kingdom

Clinical challenges and special populations
Dr Catriona Waitt
Reader in Clinical Pharmacology,University of Liverpool, Liverpool, United Kingdom

Bottom-Up mechanistic modelling for the simulation of complex clinical scenarios
Dr Marco Siccardi
Reader in Pharmacology, University of Liverpool, Liverpool, United Kingdom

Unlock your data with population pharmacokinetic modelling
Professor Paolo Denti Associate Professor in Pharmacometrics, University of Cape Town, Cape Town, South Africa

Physiologically based pharmacokinetic modelling to inform the dose escalation of atazanavir required to overcome the drug-drug interaction with rifampicin-based TB therapy
Dr Maiara Camotti-Montanha1 1 Postdoctoral Research Associate, University of Liverpool, Liverpool, United Kingdom

Population PK to inform the repurposing of esomeprazole in early-onset preeclampsia
Manna Semere Gebreyesus
MPhil Student, University of Cape Town, Cape Town, South Africa

Pharmacometric modelling of pharmacodynamic markers of treatment response in tuberculosis
Kamunkhwala Gausi
PhD Student, University of Cape Town, Cape Town, South Africa